Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue

Journal of Pathology

Volumn 189, Issue 2, 1999, Pages 213-218

  Paradis, Valérie ^a,b   Dargère, Delphine ^b   Laurendeau, Ingrid ^c   Benoît, Gérard ^a   Vidaud, Michel ^c   Jardin, Alain ^a   Bedossa, Pierre ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b CNRS   (France)

^c JE DRED 351   (France)

Author keywords

Basal cells; HTR; PIN lesion; Prostate cancer; Telomerase expression

Indexed keywords

MESSENGER RNA; TELOMERASE;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVER METASTASIS; MALE; PRECANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

AGED; DISEASE PROGRESSION; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; TELOMERASE;

EID: 0345240937     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199910)189:2<213::AID-PATH417>3.0.CO;2-A     Document Type: Article

References (38)

1. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB Telomere end-replication problem and cell aging. J Mol Biol 1992; 22: 951-960
2. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991; 256: 271-282.
3. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521-529.
4. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-573.
5. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 1995; 269: 1236-1241.
6. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
7. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994; 91: 2900-2904.
8. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55: 2533-2536.
9. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res 1995; 55: 3258-3262.
10. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-3715.
11. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92: 9082-9086.
12. Hiyama E, Hiyama K, Tatsumoto N, Shay JW, Yokoyama T. Telomerase activity in human intestine. Int J Oncol 1996; 9: 453-458.
13. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Telomerase activity in malignant and non-malignant skin conditions. J Invest Dermatol 1996; 106: 759-765.
14. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell 1985; 43: 405-412.
15. Yashima K, Piatyszek MA, Saboorian HM, et al. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997; 50: 110-117.
16. Yashima K, Litzky LA, Kaiser L, et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997; 57: 2373-2377.
17. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics. CA Cancer J Clin 1994; 44: 7-26.
18. Foster CS. Predictive factors in prostatic hyperplasia and neoplasia. Hum Pathol 1990; 21: 575-577.
19. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996; 56: 218-222.
20. Scates DK, Muir GH, Venitt S, Carmichael PL. Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer? Br J Urol 1997; 80: 263-268.
21. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, Kubota Y. Telomerase activity in primary prostate cancer. J Urol 1997; 157: 1161-1165.
22. Zhang W, Kapusta LR, Slingerland JM, Klotz LH. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium. Cancer Res 1998; 58: 619-621.
23. Blute ML, Bostwick DG, Seay TM, et al. Pathologic classification of prostate carcinoma. The impact of margin status. Cancer 1998; 82: 902-908.
24. Hiyama E, Hiyama K, Yokoyama T, et al. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1995; 3: 249-255.
25. Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996; 88: 116-122.
26. Breitkreuz T, Romanakis K, Lutz S, et al. Genotypic characterization of prostatic carcinomas: a combined cytogenetic, flow cytometry, and in situ DNA hybridization study. Cancer Res 1993; 53: 4035-4040.
27. Alers JC, Krijtenburg PJ, Vissers CJ, Bosman FT, van der Kwast TH, van Dekken H. Cytogenetic heterogeneity and histologic tumor growth patterns in prostatic cancer. Cytometry 1995; 21: 84-94.
28. Bostwick DG. High grade prostatic intraepithelial neoplasia: the most likely precursor of prostate cancer. Cancer 1995; 75: 1823-1836.
29. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of prostate. Hum Pathol 1986; 17: 64-71.
30. Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996; 29: 117-134.
31. Verhagen APM, Aalders TW, Ramaekers FCS, Debruyne FM, Schalken JA. Differential expression of keratins in the basal and luminal compartments of rat prostate epithelium during degeneration and regeneration. Prostate 1988; 13: 25-38.
32. English HF, Santen RJ, Isaacs JT. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 1987; 11: 229-242.
33. Belair CD, Yeager TR, Lopez PM, Reznikoff CA. Telomerase activity: a biomarker of cell proliferation not malignant transformation. Proc Natl Acad Sci U S A 1997; 94: 13677-13682.
34. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 1998; 58: 4168-4172.
35. Ohyashiki K, Ohyashiki J, Nishimaki J, et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 1998; 57: 2100-2103.
36. Kolquist KA, Ellisen LF, Counter CM, et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nature Genet 1998; 19: 182-186.
37. Okada H, Tsubara A, Okamura A, et al. Keratin profiles in normal/ hyperplastic prostates and prostate carcinoma. Virchows Arch 1992; 421: 157-161.
38. Liu AY, True LD, Latray L, et al. Cell-cell interaction in prostate gene regulation and cytodifferentiation. Proc Natl Acad Sci USA 1997; 94: 10705-10710.